Market Chameleon (Mon, 5-Oct 8:14 AM)
Agenus Secures $85M Financing to Launch ROBBIN Phase 3 Trial—New Hope for High-Risk Colon Cancer
Market Chameleon (Thu, 6-Aug 8:45 AM)
Agenus Expands Clinical Momentum with Three BOT+BAL Studies Accepted for ESMO 2026
Market Chameleon (Mon, 20-Jul 9:18 AM)
